These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12414959)

  • 1. Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein.
    Gerrard SR; Nichol ST
    J Virol; 2002 Dec; 76(23):12200-10. PubMed ID: 12414959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the Golgi targeting and retention signal of Bunyamwera virus glycoproteins.
    Shi X; Lappin DF; Elliott RM
    J Virol; 2004 Oct; 78(19):10793-802. PubMed ID: 15367646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the cytosolic tails of Rift Valley fever virus envelope glycoproteins in viral morphogenesis.
    Carnec X; Ermonval M; Kreher F; Flamand M; Bouloy M
    Virology; 2014 Jan; 448():1-14. PubMed ID: 24314631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of a short peptide derived from the cytoplasmic tail of the G1 membrane glycoprotein of Uukuniemi virus (Bunyaviridae) to the Golgi complex.
    Andersson AM; Pettersson RF
    J Virol; 1998 Dec; 72(12):9585-96. PubMed ID: 9811692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rift Valley fever virus M segment: cellular localization of M segment-encoded proteins.
    Wasmoen TL; Kakach LT; Collett MS
    Virology; 1988 Sep; 166(1):275-80. PubMed ID: 3046119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete sequences of the glycoproteins and M RNA of Punta Toro phlebovirus compared to those of Rift Valley fever virus.
    Ihara T; Smith J; Dalrymple JM; Bishop DH
    Virology; 1985 Jul; 144(1):246-59. PubMed ID: 2998043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retention signal necessary and sufficient for Golgi localization maps to the cytoplasmic tail of a Bunyaviridae (Uukuniemi virus) membrane glycoprotein.
    Andersson AM; Melin L; Bean A; Pettersson RF
    J Virol; 1997 Jun; 71(6):4717-27. PubMed ID: 9151865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rice stripe tenuivirus NSvc2 glycoproteins targeted to the golgi body by the N-terminal transmembrane domain and adjacent cytosolic 24 amino acids via the COP I- and COP II-dependent secretion pathway.
    Yao M; Liu X; Li S; Xu Y; Zhou Y; Zhou X; Tao X
    J Virol; 2014 Mar; 88(6):3223-34. PubMed ID: 24390331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors.
    Filone CM; Heise M; Doms RW; Bertolotti-Ciarlet A
    Virology; 2006 Dec 5-20; 356(1-2):155-64. PubMed ID: 16945399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope protein.
    Ward BM; Moss B
    J Virol; 2000 Apr; 74(8):3771-80. PubMed ID: 10729152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection.
    Gerrard SR; Bird BH; Albariño CG; Nichol ST
    Virology; 2007 Mar; 359(2):459-65. PubMed ID: 17070883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A shared transcription termination signal on negative and ambisense RNA genome segments of Rift Valley fever, sandfly fever Sicilian, and Toscana viruses.
    Albariño CG; Bird BH; Nichol ST
    J Virol; 2007 May; 81(10):5246-56. PubMed ID: 17329326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Phosphatase-1 regulates Rift Valley fever virus replication.
    Baer A; Shafagati N; Benedict A; Ammosova T; Ivanov A; Hakami RM; Terasaki K; Makino S; Nekhai S; Kehn-Hall K
    Antiviral Res; 2016 Mar; 127():79-89. PubMed ID: 26801627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the Rift Valley fever virus nucleocapsid protein reveals another architecture for RNA encapsidation.
    Raymond DD; Piper ME; Gerrard SR; Smith JL
    Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11769-74. PubMed ID: 20547879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The v-sis oncoprotein loses transforming activity when targeted to the early Golgi complex.
    Hart KC; Xu YF; Meyer AN; Lee BA; Donoghue DJ
    J Cell Biol; 1994 Dec; 127(6 Pt 2):1843-57. PubMed ID: 7806564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytoplasmic tail of infectious bronchitis virus E protein directs Golgi targeting.
    Corse E; Machamer CE
    J Virol; 2002 Feb; 76(3):1273-84. PubMed ID: 11773403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcellular sorting of small membrane-associated triple gene block proteins: TGBp3-assisted targeting of TGBp2.
    Solovyev AG; Stroganova TA; Zamyatnin AA; Fedorkin ON; Schiemann J; Morozov SY
    Virology; 2000 Mar; 269(1):113-27. PubMed ID: 10725204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins.
    Bertolotti-Ciarlet A; Smith J; Strecker K; Paragas J; Altamura LA; McFalls JM; Frias-Stäheli N; García-Sastre A; Schmaljohn CS; Doms RW
    J Virol; 2005 May; 79(10):6152-61. PubMed ID: 15858000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
    Ly HJ; Lokugamage N; Nishiyama S; Ikegami T
    PLoS One; 2017; 12(9):e0185194. PubMed ID: 28926632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rift Valley fever virus M segment: phlebovirus expression strategy and protein glycosylation.
    Kakach LT; Suzich JA; Collett MS
    Virology; 1989 Jun; 170(2):505-10. PubMed ID: 2728348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.